Company Achieves Record $12.9 Million Revenue<br><br>

Achieved a 40% Sequential Reduction in the GAAP Net Loss<br><br>

Generated Profitable Quarterly Results on a Non-GAAP Pro-Forma Basis<br><br>
</p>
<p> Achieved Positive Cash Flow From Operations for the Quarter and Year to Date</p>

AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference AngioDynamics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 31, 2006--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that its president and chief

First Three Clinical Cases Using the Investigational Starburst Assure(TM) RF Electrode Performed

RITA Medical to Present at the C.E. Unterberg, Towbin Life Sciences Conference FREMONT, Calif., Oct. 25 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it will present at the C.E.

AngioDynamics Named to Forbes 200 Best Small Companies List QUEENSBURY, N.Y., Oct 18, 2006 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced that it was named to the list of the 200 Best Small Companies in America published in the October 30, 2006 issue of Forbes.

Company Expects to Begin Shipping Product in the Second Half of the Fourth Quarter of 2006

AngioDynamics to Acquire Oncobionic and Its Revolutionary New Cancer Therapy QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 17, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) announces the signing of an agreement to acquire Oncobionic, Inc., a privately held company that has developed an irreversible

91% Reduction in Need for Re-Excision due to Inadequate Margins Reported in

Presentation at 92nd Annual Clinical Congress of the American College of

Surgeons

RITA Medical Systems Announces Third Quarter 2006 Earnings Release Date and Conference Call Fremont, Calif., Oct. 10 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it will release financial results for the third quarter ended September 30, 2006, after the

AngioDynamics Names Robert Mitchell Chief Operating Officer QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 9, 2006--AngioDynamics, Inc. (Nasdaq: ANGO), a leading provider of medical devices for the minimally invasive diagnosis and treatment of peripheral vascular disease announced today that it has

- Early Radiofrequency Ablation Treatment Demonstrates Encouraging Impact <br>
on Survival<br><br>

- Chemoembolization Using Drug-Eluting Beads Shows Promise<br><br>

- RITA RFA Devices Demonstrate Lower Local Tumor Recurrence Rate Versus<br>
Competitors

Conference Call Begins Today at 4:30 P.M. Eastern Time

AngioDynamics to Present at UBS 2006 Global Life Sciences Investor Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 20, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) announced that Joseph G. Gerardi, AngioDynamics' chief financial officer, will present at the UBS 2006 Global Life Sciences Conference

AngioDynamics to Hold Fiscal 2007 First Quarter Financial Results Conference Call on Monday, September 25, 2006 QUEENSBURY, N.Y., Sep 18, 2006 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the company will release fiscal 2007 first quarter results after the market closes

AngioDynamics Comments on Declaratory Judgment Decision by Court QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 8, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today commented on a decision in the U.S. District Court for Delaware concerning a declaratory judgment action brought by AngioDynamics against

U.S. Congressman Sweeney to Attend AngioDynamics Facility Expansion Ceremony QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 6, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that U.S. Congressman John E. Sweeney (R-N.Y.) will attend AngioDynamics' facility expansion ceremony on Friday, September

RITA Medical to Present at the Thomas Weisel Partners Healthcare Conference 2006 FREMONT, Calif., Sept. 6 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it will present at the

AngioDynamics Announces That Court Denies Diomed's Summary Motion for Infringement QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 31, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the U. S. District Judge Nathaniel M. Gorton has ruled on summary judgment motions in the Diomed patent

AngioDynamics Fourth Quarter Results Feature Net Sales up 36%; Company Introduces Fiscal 2007 Financial Guidance; Conference Call Begins Today at 4:30 p.m. Eastern Time QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 10, 2006--AngioDynamics, Inc. (Nasdaq: ANGO) today announced financial results for the 13

Company Achieves Record $12.8 Million Revenue; Expects Key Product
Introductions in Second Half of Year